SEC
IONS icon

Seven Eight Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Seven Eight Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,394
Closed -$697K – 297
2024
Q3 		$697K Buy
+17,394
New +$809K 0.06% 488
2023
Q3 		– Sell
-6,178
Closed -$253K – 653
2023
Q2 		$253K Buy
+6,178
New +$237K 0.04% 422
2023
Q1 		– Sell
-5,990
Closed -$226K – 520
2022
Q4 		$226K Buy
5,990
+700
+13% +$29.4K 0.06% 352
2022
Q3 		$234K Sell
5,290
-167
-3% -$7.04K 0.05% 427
2022
Q2 		$202K Sell
5,457
-10,339
-65% -$390K 0.08% 342
2022
Q1 		$585K Buy
+15,796
New +$517K 0.08% 299
2020
Q4 		– Sell
-21,600
Closed -$1.02M – 513
2020
Q3 		$1.02M Buy
+21,600
New +$1.2M 0.22% 159
2019
Q2 		– Sell
-11,670
Closed -$947K – 655
2019
Q1 		$947K Buy
+11,670
New +$753K 0.05% 365
2015
Q3 		– Sell
-6,893
Closed -$397K – 605
2015
Q2 		$397K Buy
+6,893
New +$438K 0.47% 57
2015
Q1 		– Sell
-4,893
Closed -$302K – 582
2014
Q4 		$302K Buy
4,893
+2,263
+86% +$112K 0.5% 61
2014
Q3 		$102K Buy
+2,630
New +$93.2K 0.08% 321

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Seven Eight Capital's IONS Position: Q4 2024 in Review

Seven Eight Capital sold out of Ionis Pharmaceuticals (IONS) in Q4 2024, closing a stake of 17,394 shares — an estimated $697K sold.

Seven Eight Capital first reported a position in IONS in Q3 2014 and held it in 11 quarters. The position peaked at $1.02M in Q3 2020. 354 funds tracked by Wall St. Rank hold IONS as of Q4 2024.

  • Seven Eight Capital reported no remaining Ionis Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 17,394 Ionis Pharmaceuticals shares in Q4 2024, an estimated $697K.
  • Seven Eight Capital first reported a position in Ionis Pharmaceuticals in Q3 2014 and held it in 11 quarters.
  • Seven Eight Capital's Ionis Pharmaceuticals position peaked at $1.02M in Q3 2020.
  • 354 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.